BridgeMD
New treatment option for Parkinson Disease, Idiopathic
Official title Strength-Endurance Circuit Training in Parkinson's Disease
ClinicalTrials.gov ID: NCT06893055
What this study is testing
- What it's testing
- The goal of this clinical trial is to determine whether adding strength training to aerobic training has a comparable or greater effect on the clinical status of Parkinson's disease patients than a standalone aerobic training. \- Does combined strength-endurance circuit training provide added benefits to physical performance, disease severity, blood biomarkers, and quality of life in PD patients compared to standalone aerobic training?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- age ≥18 years
- diagnosis of idiopathic Parkinson´s disease
- Hoehn-Yahr Scale ≤ 2,5
- stable dopaminergic medication
You likely can't join if
- age ≥75 years
- Hoehn-Yahr Scale ≥ 2,5
- deep brain stimulation
- presence of freezing
- Camptocormia
- inability to walk without support
See the full eligibility criteria
- age ≥18 years
- diagnosis of idiopathic Parkinson´s disease
- Hoehn-Yahr Scale ≤ 2,5
- stable dopaminergic medication
- age ≥75 years
- Hoehn-Yahr Scale ≥ 2,5
- deep brain stimulation
- presence of freezing
- Camptocormia
- inability to walk without support
- inability to perform study procedures
- limiting co-morbidities
- attendance at training sessions below 70%
The study team makes the final eligibility decision.
Where it's taking place
- Prague, Prague, Czechia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Prague, Prague, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.